carbidopa has been researched along with n-methyl-3,4-methylenedioxyamphetamine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gudelsky, GA; Nash, JF | 1 |
Bernardi, G; Federici, M; Mercuri, NB; Natoli, S; Sebastianelli, L | 1 |
2 other study(ies) available for carbidopa and n-methyl-3,4-methylenedioxyamphetamine
Article | Year |
---|---|
Carrier-mediated release of serotonin by 3,4-methylenedioxymethamphetamine: implications for serotonin-dopamine interactions.
Topics: 5-Hydroxytryptophan; Animals; Carbidopa; Carrier Proteins; Corpus Striatum; Dopamine; Drug Synergism; Fluoxetine; Frontal Lobe; Male; Membrane Glycoproteins; Membrane Transport Proteins; N-Methyl-3,4-methylenedioxyamphetamine; Nerve Tissue Proteins; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Agents; Serotonin Plasma Membrane Transport Proteins; Tetrodotoxin | 1996 |
Electrophysiologic changes in ventral midbrain dopaminergic neurons resulting from (+/-) -3,4-methylenedioxymethamphetamine (MDMA-"Ecstasy").
Topics: Action Potentials; Amphetamine; Animals; Autoreceptors; Carbidopa; Cocaine; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Hallucinogens; Membrane Potentials; Mesencephalon; N-Methyl-3,4-methylenedioxyamphetamine; Neural Inhibition; Neurons; Pindolol; Receptors, Dopamine D2; Ventral Tegmental Area | 2007 |